Switch to:
Also traded in: Canada, Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 8/10

vs
industry
vs
history
Cash-to-Debt No Debt
JCOUF's Cash-to-Debt is ranked higher than
99% of the 364 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.53 vs. JCOUF: No Debt )
Ranked among companies with meaningful Cash-to-Debt only.
JCOUF' s Cash-to-Debt Range Over the Past 10 Years
Min: 0  Med: 1.29 Max: No Debt
Current: No Debt
Equity-to-Asset 0.82
JCOUF's Equity-to-Asset is ranked higher than
94% of the 359 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.42 vs. JCOUF: 0.82 )
Ranked among companies with meaningful Equity-to-Asset only.
JCOUF' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.25  Med: 0.57 Max: 0.87
Current: 0.82
0.25
0.87
Interest Coverage 530.60
JCOUF's Interest Coverage is ranked higher than
79% of the 328 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 19.81 vs. JCOUF: 530.60 )
Ranked among companies with meaningful Interest Coverage only.
JCOUF' s Interest Coverage Range Over the Past 10 Years
Min: 1.91  Med: 252.24 Max: 755
Current: 530.6
1.91
755
Piotroski F-Score: 6
Altman Z-Score: 12.94
Beneish M-Score: -2.35
WACC vs ROIC
0.34%
18.76%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating Margin % 8.83
JCOUF's Operating Margin % is ranked higher than
89% of the 364 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.88 vs. JCOUF: 8.83 )
Ranked among companies with meaningful Operating Margin % only.
JCOUF' s Operating Margin % Range Over the Past 10 Years
Min: 3.51  Med: 10.14 Max: 11.05
Current: 8.83
3.51
11.05
Net Margin % 6.52
JCOUF's Net Margin % is ranked higher than
90% of the 365 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.94 vs. JCOUF: 6.52 )
Ranked among companies with meaningful Net Margin % only.
JCOUF' s Net Margin % Range Over the Past 10 Years
Min: -50.31  Med: 7.24 Max: 20.38
Current: 6.52
-50.31
20.38
ROE % 16.48
JCOUF's ROE % is ranked higher than
79% of the 357 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 8.73 vs. JCOUF: 16.48 )
Ranked among companies with meaningful ROE % only.
JCOUF' s ROE % Range Over the Past 10 Years
Min: -96.41  Med: 22.84 Max: 63.43
Current: 16.48
-96.41
63.43
ROA % 13.32
JCOUF's ROA % is ranked higher than
94% of the 368 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 3.40 vs. JCOUF: 13.32 )
Ranked among companies with meaningful ROA % only.
JCOUF' s ROA % Range Over the Past 10 Years
Min: -71.15  Med: 16.58 Max: 45.28
Current: 13.32
-71.15
45.28
ROC (Joel Greenblatt) % 36.87
JCOUF's ROC (Joel Greenblatt) % is ranked higher than
84% of the 365 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 14.30 vs. JCOUF: 36.87 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
JCOUF' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 28.37  Med: 51.77 Max: 126.2
Current: 36.87
28.37
126.2
3-Year Revenue Growth Rate 6.80
JCOUF's 3-Year Revenue Growth Rate is ranked higher than
63% of the 331 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 4.10 vs. JCOUF: 6.80 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
JCOUF' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -40.8  Med: 8.6 Max: 44.9
Current: 6.8
-40.8
44.9
3-Year EBITDA Growth Rate -13.90
JCOUF's 3-Year EBITDA Growth Rate is ranked lower than
86% of the 299 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 6.70 vs. JCOUF: -13.90 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
JCOUF' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -24.9  Med: 13.6 Max: 48.8
Current: -13.9
-24.9
48.8
3-Year EPS without NRI Growth Rate -20.10
JCOUF's 3-Year EPS without NRI Growth Rate is ranked lower than
88% of the 265 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 7.60 vs. JCOUF: -20.10 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
JCOUF' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -23.7  Med: 11.7 Max: 74.9
Current: -20.1
-23.7
74.9
GuruFocus has detected 3 Warning Signs with The Jean Coutu Group (PJC) Inc $JCOUF.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» JCOUF's 30-Y Financials

Financials (Next Earnings Date: 2017-10-11 Est.)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Insider Trades

Latest Guru Trades with JCOUF

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Retail - Defensive » Pharmaceutical Retailers    NAICS: 446199    SIC: 6032
Compare:TSXV:WELL » details
Traded in other countries:PJC.A.Canada, CJN.Germany,
Headquarter Location:Canada
The Jean Coutu Group (PJC) Inc is a pharmacy retailing company. It operates a network of franchised stores under the banners of PJC Jean Coutu, PJC Clinique, PJC Jean Coutu Sante and PJC Jean Coutu Sante Beaute.

The Jean Coutu Group is a Canadian pharmaceutical retailer that operates under a franchise model. The company reports three segments: franchising, generic medicines, and intersegment sales. The company's stores sell branded and generic medication, over-the-counter medicine, health and beauty aids, perfumes, discount cosmetic lines, photography services, household items, pet supplies, groceries, and personal-care products. The bulk of Jean Coutu's revenue comes from prescription drug sales.

Top Ranked Articles about The Jean Coutu Group (PJC) Inc

The Jean Coutu Group to Hold Second Quarter of Fiscal 2017 Results Conference Call

VARENNES, QUEBEC--(Marketwired - Sep 20, 2016) - The Jean Coutu Group (PJC) Inc. (TSX:PJC.A) announced today that the release of results for the second quarter of fiscal 2017 will take place on October 5, 2016 at approximately 7:00 a.m. ET. Financial analysts and investors are invited to attend a conference call during which the financial results will be presented.


Time and date:
Wednesday, October 5, 2016, at 9:00 a.m. ET


Dial number:
514-392-1478 or 866-225-0198


Conference call name:
The Jean Coutu Group (PJC) Inc.



Media and other interested individuals are invited to listen to the live or deferred broadcast on the Jean Coutu Group corporate website at www.jeancoutu.com. A full replay will also be available by dialling 514-861-2272 or toll free at 800-408-3053 until November 4, 2016. The access code is 7278588 followed by pound sign (#). About The Jean Coutu Group The Jean Coutu Group is one of the most trusted names in Canadian pharmacy retailing. The Corporation operates a network of 420 franchised stores in Québec, New Brunswick and Ontario under the banners of PJC Jean Coutu, PJC Clinique, PJC Santé and PJC Santé Beauté, and employs more than 20,000 people. Furthermore, since December 2007, the Jean Coutu Group owns Pro Doc Ltd ("Pro Doc"), a Québec-based subsidiary and manufacturer of generic drugs. Website: www.jeancoutu.com






Source: The Jean Coutu Group (PJC) Inc.
Information: Helene Bisson
Vice President, Communications
(450) 646-9611, ext. 1165




Read more...

Ratios

vs
industry
vs
history
PE Ratio 21.04
JCOUF's PE Ratio is ranked higher than
60% of the 304 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 20.17 vs. JCOUF: 21.04 )
Ranked among companies with meaningful PE Ratio only.
JCOUF' s PE Ratio Range Over the Past 10 Years
Min: 5.38  Med: 14.33 Max: 822.11
Current: 21.04
5.38
822.11
Forward PE Ratio 19.80
JCOUF's Forward PE Ratio is ranked lower than
55% of the 65 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 17.76 vs. JCOUF: 19.80 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 21.04
JCOUF's PE Ratio without NRI is ranked higher than
61% of the 302 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 20.55 vs. JCOUF: 21.04 )
Ranked among companies with meaningful PE Ratio without NRI only.
JCOUF' s PE Ratio without NRI Range Over the Past 10 Years
Min: 5.38  Med: 14.56 Max: 781
Current: 21.04
5.38
781
Price-to-Owner-Earnings 27.25
JCOUF's Price-to-Owner-Earnings is ranked lower than
59% of the 203 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 21.21 vs. JCOUF: 27.25 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
JCOUF' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 9.22  Med: 21.77 Max: 46.9
Current: 27.25
9.22
46.9
PB Ratio 3.35
JCOUF's PB Ratio is ranked lower than
70% of the 352 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.77 vs. JCOUF: 3.35 )
Ranked among companies with meaningful PB Ratio only.
JCOUF' s PB Ratio Range Over the Past 10 Years
Min: 1.5  Med: 3.59 Max: 5.66
Current: 3.35
1.5
5.66
PS Ratio 1.38
JCOUF's PS Ratio is ranked lower than
80% of the 356 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.49 vs. JCOUF: 1.38 )
Ranked among companies with meaningful PS Ratio only.
JCOUF' s PS Ratio Range Over the Past 10 Years
Min: 0.25  Med: 1.17 Max: 1.94
Current: 1.38
0.25
1.94
Price-to-Free-Cash-Flow 23.13
JCOUF's Price-to-Free-Cash-Flow is ranked lower than
52% of the 143 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 20.04 vs. JCOUF: 23.13 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
JCOUF' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 12.6  Med: 20.01 Max: 5730
Current: 23.13
12.6
5730
Price-to-Operating-Cash-Flow 20.24
JCOUF's Price-to-Operating-Cash-Flow is ranked lower than
79% of the 187 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 10.78 vs. JCOUF: 20.24 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
JCOUF' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 7.97  Med: 14.71 Max: 79.03
Current: 20.24
7.97
79.03
EV-to-EBIT 14.90
JCOUF's EV-to-EBIT is ranked higher than
64% of the 316 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 16.11 vs. JCOUF: 14.90 )
Ranked among companies with meaningful EV-to-EBIT only.
JCOUF' s EV-to-EBIT Range Over the Past 10 Years
Min: 5.1  Med: 10.6 Max: 32.3
Current: 14.9
5.1
32.3
EV-to-EBITDA 12.95
JCOUF's EV-to-EBITDA is ranked higher than
56% of the 324 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 11.79 vs. JCOUF: 12.95 )
Ranked among companies with meaningful EV-to-EBITDA only.
JCOUF' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.9  Med: 9.6 Max: 16.7
Current: 12.95
4.9
16.7
EV-to-Revenue 1.33
JCOUF's EV-to-Revenue is ranked lower than
76% of the 361 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.58 vs. JCOUF: 1.33 )
Ranked among companies with meaningful EV-to-Revenue only.
JCOUF' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.3  Med: 1.2 Max: 1.9
Current: 1.33
0.3
1.9
Shiller PE Ratio 51.03
JCOUF's Shiller PE Ratio is ranked lower than
87% of the 86 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 22.04 vs. JCOUF: 51.03 )
Ranked among companies with meaningful Shiller PE Ratio only.
JCOUF' s Shiller PE Ratio Range Over the Past 10 Years
Min: 39.38  Med: 62.5 Max: 119.54
Current: 51.03
39.38
119.54
Current Ratio 2.86
JCOUF's Current Ratio is ranked higher than
86% of the 360 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.22 vs. JCOUF: 2.86 )
Ranked among companies with meaningful Current Ratio only.
JCOUF' s Current Ratio Range Over the Past 10 Years
Min: 0.83  Med: 1.85 Max: 3.95
Current: 2.86
0.83
3.95
Quick Ratio 1.84
JCOUF's Quick Ratio is ranked higher than
81% of the 360 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.76 vs. JCOUF: 1.84 )
Ranked among companies with meaningful Quick Ratio only.
JCOUF' s Quick Ratio Range Over the Past 10 Years
Min: 0.39  Med: 0.84 Max: 3.04
Current: 1.84
0.39
3.04
Days Inventory 40.15
JCOUF's Days Inventory is ranked higher than
50% of the 355 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 39.51 vs. JCOUF: 40.15 )
Ranked among companies with meaningful Days Inventory only.
JCOUF' s Days Inventory Range Over the Past 10 Years
Min: 27.97  Med: 31.21 Max: 40.7
Current: 40.15
27.97
40.7
Days Sales Outstanding 29.04
JCOUF's Days Sales Outstanding is ranked lower than
64% of the 274 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 13.78 vs. JCOUF: 29.04 )
Ranked among companies with meaningful Days Sales Outstanding only.
JCOUF' s Days Sales Outstanding Range Over the Past 10 Years
Min: 4.47  Med: 27.09 Max: 29.04
Current: 29.04
4.47
29.04

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield % 1.71
JCOUF's Dividend Yield % is ranked higher than
63% of the 477 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.95 vs. JCOUF: 1.71 )
Ranked among companies with meaningful Dividend Yield % only.
JCOUF' s Dividend Yield % Range Over the Past 10 Years
Min: 0.74  Med: 1.82 Max: 2.51
Current: 1.71
0.74
2.51
Dividend Payout Ratio 0.35
JCOUF's Dividend Payout Ratio is ranked higher than
73% of the 289 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 0.33 vs. JCOUF: 0.35 )
Ranked among companies with meaningful Dividend Payout Ratio only.
JCOUF' s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.11  Med: 0.28 Max: 0.44
Current: 0.35
0.11
0.44
3-Year Dividend Growth Rate 12.20
JCOUF's 3-Year Dividend Growth Rate is ranked higher than
62% of the 184 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 7.40 vs. JCOUF: 12.20 )
Ranked among companies with meaningful 3-Year Dividend Growth Rate only.
JCOUF' s 3-Year Dividend Growth Rate Range Over the Past 10 Years
Min: 0  Med: 14.5 Max: 35.7
Current: 12.2
0
35.7
Forward Dividend Yield % 2.42
JCOUF's Forward Dividend Yield % is ranked higher than
60% of the 464 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.20 vs. JCOUF: 2.42 )
Ranked among companies with meaningful Forward Dividend Yield % only.
N/A
5-Year Yield-on-Cost % 3.48
JCOUF's 5-Year Yield-on-Cost % is ranked higher than
74% of the 526 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.96 vs. JCOUF: 3.48 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
JCOUF' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.51  Med: 3.71 Max: 5.11
Current: 3.48
1.51
5.11
3-Year Average Share Buyback Ratio 3.60
JCOUF's 3-Year Average Share Buyback Ratio is ranked higher than
92% of the 207 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: -0.70 vs. JCOUF: 3.60 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
JCOUF' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -5  Med: -0.1 Max: 5.3
Current: 3.6
-5
5.3

Valuation & Return

vs
industry
vs
history
Price-to-Net-Current-Asset-Value 9.93
JCOUF's Price-to-Net-Current-Asset-Value is ranked lower than
67% of the 129 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.30 vs. JCOUF: 9.93 )
Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.
JCOUF' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 6.04  Med: 25.78 Max: 400
Current: 9.93
6.04
400
Price-to-Tangible-Book 4.14
JCOUF's Price-to-Tangible-Book is ranked lower than
70% of the 314 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 2.07 vs. JCOUF: 4.14 )
Ranked among companies with meaningful Price-to-Tangible-Book only.
JCOUF' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.34  Med: 3.86 Max: 7.29
Current: 4.14
1.34
7.29
Price-to-Intrinsic-Value-Projected-FCF 1.52
JCOUF's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
56% of the 228 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.47 vs. JCOUF: 1.52 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
JCOUF' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.99  Med: 1.72 Max: 5.23
Current: 1.52
0.99
5.23
Price-to-Median-PS-Value 1.18
JCOUF's Price-to-Median-PS-Value is ranked higher than
50% of the 334 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.10 vs. JCOUF: 1.18 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
JCOUF' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.22  Med: 0.71 Max: 1.58
Current: 1.18
0.22
1.58
Price-to-Graham-Number 1.97
JCOUF's Price-to-Graham-Number is ranked lower than
57% of the 265 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 1.48 vs. JCOUF: 1.97 )
Ranked among companies with meaningful Price-to-Graham-Number only.
JCOUF' s Price-to-Graham-Number Range Over the Past 10 Years
Min: 0.78  Med: 1.71 Max: 6.67
Current: 1.97
0.78
6.67
Earnings Yield (Greenblatt) % 6.71
JCOUF's Earnings Yield (Greenblatt) % is ranked higher than
69% of the 368 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 5.52 vs. JCOUF: 6.71 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
JCOUF' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 3.1  Med: 9.4 Max: 19.5
Current: 6.71
3.1
19.5
Forward Rate of Return (Yacktman) % -2.02
JCOUF's Forward Rate of Return (Yacktman) % is ranked lower than
68% of the 244 Companies
in the Global Pharmaceutical Retailers industry.

( Industry Median: 7.90 vs. JCOUF: -2.02 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
JCOUF' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -17.3  Med: 6.1 Max: 34.5
Current: -2.02
-17.3
34.5

More Statistics

Revenue (TTM) (Mil) $2,261.65
EPS (TTM) $ 0.81
Beta0.39
Short Percentage of Float0.00%
52-Week Range $14.58 - 17.24
Shares Outstanding (Mil)183.70

Analyst Estimate

Feb18 Feb19 Feb20
Revenue (Mil $) 2,422 2,474
EPS ($) 0.85 0.92 0.99
EPS without NRI ($) 0.85 0.92 0.99
EPS Growth Rate
(Future 3Y To 5Y Estimate)
N/A
Dividends per Share ($)

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}